Beam Therapeutics Inc. Insider Selling: John Evans M. Trims Stake

A Form 4 filed with the SEC shows John Evans M., CEO at Beam Therapeutics Inc. (BEAM), sold 50,000 shares of company stock on 2026-10-15.

The transaction was executed at a price of $23.77 per share, for a total value of approximately $1.19 million.

Under SEC rules, corporate insiders — officers, directors, and holders of more than 10% of a company's shares — are required to report changes in their ownership within two business days of the transaction via Form 4.

Insider sales are common and can occur for reasons unrelated to a company's outlook, including scheduled trading plans, diversification, or personal financial planning.